Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NuVasive sets IPO (initial public offering) for up to $97 million

This article was originally published in Clinica

Executive Summary

NuVasive, a spinal technology developer whose financial backers include Johnson & Johnson Development Corporation and William Blair Capital Partners, has set $97.1m as the new upper limit for its impending initial public offering on Nasdaq. In March the company filed a registration statement with the SEC for a maximum upper limit of $92m (see Clinica No 1099, p 16).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts